Serous Ovarian Cancer Following Opportunistic Bilateral Salpingectomy

JAMA Network Open 2026 Open access

Read full text
Authors: Ramlogan Sowamber, Alice J. Mei, Paramdeep Kaur, Julianne McLeod, Emily McKay, Alex Lukey, Jamie Bakkum-Gamez, Natalia Buza, Paul A. Cohen, Kyle M. Devins, Rhonda Farrell, Christine Garcia
+36 more Blake Gilks, Ellen Goode, Anjelica Hodgson, Brooke Howitt, Pei Hui, Jutta Huvila, Anthony N. Karnezis, Kianoosh Keyhanian, Mary Kinloch, Martin Köbel, F. Kommoss, Lawrence Kushi, Janice Kwon, Kara C. Long-Roche, Anais Malpica, Jessica N. McAlpine, Dianne Miller, Esther Oliva, Andrea Palicelli, Aleksandra Paliga, Carlos Parra-Herran, Celeste Leigh Pearce, Sharnel Perera, Jurgen Martinus Piek, Haiyan Qiu, Joseph T. Rabban, Robert Rome, Miranda Steenbeek, R. Stone, Aline Talhouk, Kristin M. Tischer, Britton Trabert, Penelope M. Webb, John Zalcberg, David G. Huntsman, Gillian E. Hanley
DOI: 10.1001/jamanetworkopen.2025.57267
Cited by: 7
References: 6

Abstract

This cohort study evaluates the reduction in risk of high-grade serous carcinoma among women undergoing opportunistic bilateral salpingectomy in Canada.

Fields of Study & Subjects

Ovarian cancer diagnosis and treatment Menopause: Health Impacts and Treatments Endometrial and Cervical Cancer Treatments

Publication details

Journal / source
JAMA Network Open
Publisher
American Medical Association (AMA)
Volume
9
Issue
2
Pages
e2557267–e2557267
Publication date
2 February 2026
Language
EN